U.S. market Closed. Opens in 11 hours 46 minutes

BLTE | Belite Bio, Inc Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-31
RevenueN/AN/AN/AN/A
Cost of Revenue399.00K198.00K30.00K17.00K
Gross Profit-399.00K-198.00K-30.00K-17.00K
Operating Expenses31.27M12.82M9.80M5.74M
Selling, General & Admin6.42M3.95M2.38M2.06M
Research & Development24.84M8.87M7.42M3.69M
Other Operating ExpensesN/A166.00K126.00KN/A
Operating Income-31.67M-12.82M-9.80M-5.74M
Other Expenses / Income45.00K173.00K131.00K-9.00K
Before Tax Income-31.62M-12.65M-9.67M-5.75M
Income Tax Expenses9.00K-173.00K126.00K1.00K
Net Income-31.63M-12.47M-9.79M-5.75M
Interest Expenses25.00K16.00KN/A21.00K
Basic Shares Outstanding26.59M19.98M24.10M24.10M
Diluted Shares Outstanding26.59M19.98M24.10M24.10M
EBITDA-31.27M-12.43M-9.64M-5.71M
EBITDA Margin0.00%0.00%0.00%0.00%
EBIT-31.60M-12.63M-9.67M-5.73M
EBIT Margin0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙